Suven Life Sciences Limited

NSE:SUVEN.NS

211.67 (INR) • At close September 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12017 Q42016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q1
Revenue 18.66714.6716.09925.72910.0623.85224.50830.59637.97326.11130.02443.86535.39242.21244.32911.84120.06115.57115.1389.79614.28686.627.7262,743.1491,989.8633,620.59221.057895.2181,916.6221,801.4791,693.721,125.0431,167.6141,009.8141,106.6251,288.2971,398.3121,415.3161,308.0341,194.2711,514.1231,086.696747.036623.948502.59705.272
Cost of Revenue 093.09482.15986.51881.12266.59886.2477.98986.89968.99874.06183.60179.49995.82380.61475.20670.9461.0310000.22701,186.787666.8851,547.6774.698307.037874.062453.218491.151556.632343.924440.694552.605520.487769.895608.707583.828389.274476.116338.924396.748260.562227.546332.402
Gross Profit 18.667-78.42416.09925.729-71.062-42.746-61.732-47.393-48.926-42.887-44.037-39.736-44.107-53.611-36.285-63.365-50.88514.5415.1389.79614.28686.37327.7261,556.3621,322.9782,072.91516.359588.1811,042.561,348.2611,202.569568.411823.69569.12554.02767.81628.417806.609724.206804.9971,038.007747.772350.288363.386275.044372.87
Gross Profit Ratio 1-5.34611-7.064-1.792-2.519-1.549-1.288-1.642-1.467-0.906-1.246-1.27-0.819-5.351-2.5370.9341110.99710.5670.6650.5730.7770.6570.5440.7480.710.5050.7050.5640.5010.5960.4490.570.5540.6740.6860.6880.4690.5820.5470.529
Reseach & Development Expenses 414.884373.25341.332475.849249.187275.217416.219204.973247.863289.043488.525193.446182.496154.575300.731223.146385.223179.558227.374197.974105.367278.377237.078227.938428.571358.363136.967257.337277.579192.375160.056151.696150.629159.36232.318127.947109.87289.489123.80597.308178.97979.38798.21392.97268.2887.468
General & Administrative Expenses 000000000000000000000000023.6750000102.565000107.47900075.265037.4833.238137.81635.95868.0161.763
Selling & Marketing Expenses 000000000000000000000000025.518000024.10600016.48500067.122030.58811.04712.686000
SG&A 0048.658-450.1246.89634.64857.93744.48752.80339.33647.57550.78548.51357.61950.60151.43550.55341.7945.01457.17441.38244.13533.226172.393194.24449.19369.768146.488177.5980126.671115.802110.75795.422123.96496.34278.11991.137267.29289.39768.06844.28585.60835.95868.0161.763
Other Expenses 124.95033.501536.63840.08342.83160.65651.41756.39656.02222.0492.0614.358-51.8591.4095.02845.55213.23116.24122.77225.29364.31858.55355.85230.067-211.24467.40865.86281.27749.38542.318175.856352.84137.661264.042158.353145.258151.396167.049172.82497.889183.176145.20846.85377.21378.249
Operating Expenses 539.834373.25423.491562.367249.187275.217502.459282.962334.762358.041562.586277.047261.995243.36381.344298.352456.169230.449292.616276.472166.901342.695312.972592.727784.044925.371228.58541.045643.485491.508383.655327.552503.469297.021496.36286.3255.13240.885290.854270.132344.936306.848243.421224213.503227.48
Operating Income -521.167-451.674-407.392-536.638-320.249-317.963-417.295-200.949-296.789-275.908-510.513-231.121-226.603-208.187-337.015-286.511-436.108-214.878-277.486-186.676-152.615-256.095-285.246963.635538.9341,147.544-207.52347.136399.075856.753818.914240.859320.221272.09957.66481.51373.287565.724433.352534.865693.071440.924106.867139.38661.541145.39
Operating Income Ratio -27.919-30.789-25.305-20.857-31.834-13.331-17.027-6.568-7.816-10.567-17.003-5.269-6.403-4.932-7.603-24.197-21.739-13.8-18.34-2.079-10.683-2.957-10.2880.3510.2710.317-9.8550.0530.2080.4760.4840.2140.2740.2690.0520.3740.2670.40.3310.4480.4580.4060.1430.2230.1220.206
Total Other Income Expenses Net 5.99812.22516.22640.239.85240.42931.99974.14755.884-0.541-5.0761.36763.341-6.8330.1133.52944.023-14.807-5.73920.16423.05-0.36257.53232.94213.1953.29567.40959.92570.573-413.219-359.448-15.386-13.952-9.224168.825-10.055-31.307-11.6422,074.366-22.143-34.128-31.906-14.033-46.853-1.474-32.192
Income Before Tax -515.169-439.449-391.166-496.438-280.397-275.431-417.649-126.802-240.905-276.449-511.152-231.815-163.262-207.981-336.903-282.982-392.085-215.666-262.997-166.512-129.565-233.595-227.714996.577552.1291,150.839-140.114107.061469.648443.534459.466225.473306.269262.875226.485447.797327.782513.483446.696512.722658.943409.01892.83483.59563.99388.102
Income Before Tax Ratio -27.598-29.956-24.298-19.295-27.872-11.548-17.041-4.144-6.344-10.587-17.025-5.285-4.613-4.927-7.6-23.898-19.545-13.85-17.382-1.854-9.069-2.697-8.2130.3630.2770.318-6.6540.120.2450.2460.2710.20.2620.260.2050.3480.2340.3630.3420.4290.4350.3760.1240.1340.1270.125
Income Tax Expense 00000-10.02416.069000000-38.6491.408000.458-19.068-9.946-24.67221.9870.422363.457290.039436.6823.8968.401209.40642.83787.68648.2858.98360.56856.995125.53179.417166.101122.64148.39203.475111.2996.536.027-0.8968.468
Net Income -515.169-439.449-391.166-496.438-280.397-265.407-417.649-126.802-240.905-276.449-511.152-231.815-163.262-207.981-336.903-282.982-392.085-216.124-243.929-156.566-104.893-255.582-228.136633.12262.09714.157-144.00438.66260.242400.697371.78177.193247.286202.307169.49322.266248.365347.382324.056364.332455.468297.71986.30477.56864.88979.634
Net Income Ratio -27.598-29.956-24.298-19.295-27.872-11.127-17.041-4.144-6.344-10.587-17.025-5.285-4.613-4.927-7.6-23.898-19.545-13.88-16.122-1.744-7.342-2.951-8.2280.2310.1320.197-6.8390.0430.1360.2220.220.1570.2120.20.1530.250.1780.2450.2480.3050.3010.2740.1160.1240.1290.113
EPS -2.36-2.01-1.79-2.27-1.29-1.68-2.65-0.8-1.53-1.75-3.24-1.47-1.03-1.32-2.14-1.79-2.49-1.37-1.55-0.99-0.66-1.62-1.45-1.44-1.895.61-0.910.281.882.922.681.281.791.471.332.521.962.742.552.873.592.350.680.610.520.63
EPS Diluted -2.36-2.01-1.79-2.27-1.29-1.68-2.64-0.8-1.52-1.75-3.23-1.47-1.03-1.31-2.13-1.79-2.48-1.37-1.54-0.99-0.66-1.62-1.44-1.44-1.895.61-0.910.281.882.922.681.281.791.471.332.521.962.742.552.873.592.350.680.610.520.63
EBITDA -501.485-425.982-375.752-481.731-265.302-260.048-401.266-109.119-223.748-259.189-493.807-214.925-146.434-195.98-323.384-271.14-380.213-202.591-249.834-153.158-116.673-220.748-218.1431,075.395624.5041,300.11-130.237168.603535.433531.047531.967286.055365.201301.145168.221482.325365.889554.964456.103557.348715.263461.872130.916152.34978.546163.713
EBITDA Ratio -26.865-29.038-23.34-18.723-26.372-10.903-16.373-3.566-5.892-9.926-16.447-4.9-4.137-4.643-7.295-22.898-18.953-13.011-16.512-1.706-8.167-2.549-7.8680.3920.3140.359-6.1850.1880.2790.2950.3140.2540.3130.2980.1520.3740.2620.3920.3490.4670.4720.4250.1750.2440.1560.232